Cargando…
Non-HDL-cholesterol as valid surrogate to apolipoprotein B(100 )measurement in diabetes: Discriminant Ratio and unbiased equivalence
BACKGROUND: Apolipoprotein B(100 )(apoB) is a superior indicator of CV risk than total or LDL-C. Non-HDL-C represents a simple surrogate for apoB in hypertriglyceridemic and/or T2DM patients. ApoB and non-HDL-C show high correlation, although the degree of mutual concordance remains debated in CV ri...
Autores principales: | Hermans, Michel P, Sacks, Frank M, Ahn, Sylvie A, Rousseau, Michel F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056766/ https://www.ncbi.nlm.nih.gov/pubmed/21356116 http://dx.doi.org/10.1186/1475-2840-10-20 |
Ejemplares similares
-
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B(100) in patients with T2DM
por: Hermans, Michel P, et al.
Publicado: (2013) -
Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids
por: Hermans, Michel P, et al.
Publicado: (2014) -
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males
por: Hermans, Michel P, et al.
Publicado: (2010) -
Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023) -
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females
por: Hermans, Michel P, et al.
Publicado: (2012)